| NICOX SA INH. EO 0,01 |
| Frankreich |
| Gesundheit |
| FR0013018124 / A143G8 |
| NXOA (Frankfurt) |
| FRA:NXOA, ETR:NXOA, NXOA:GR |
| - |
| https://www.nicox.com/ |
|
Nicox S.A. is a pharmaceutical company dedicated to the development and commercialization of innovative ophthalmic solutions. The primary focus of Nicox is on advancing therapies that address significant unmet needs in the field of eye care, includin..
>Volltext.. |
| 34.19 Mio. EUR |
| 43.25 Mio. EUR |
| 3.38 Mio. EUR |
| -41.22 Mio. EUR |
| -27.56 Mio. EUR |
| -0.39 EUR |
| 15.12 Mio. EUR |
| 5.81 Mio. EUR |
| - |
| 0.33 |
| -55.77% |
| - |
| - |
| - |
| - |
| - |
| NICOX |
| 02.04.26 |
|